India to United Kingdom: Anastrozole Export Trade Route
India has recorded 53 verified shipments of Anastrozole exported to United Kingdom, representing a combined trade value of $752.5K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $14.2K USD. The leading Indian exporter is NATCO PHARMA LIMITED, which accounts for 44% of total export value with 6 shipments worth $329.1K USD. On the buying side, LEXON UK LIMITED is the largest importer in United Kingdom with $275.0K USD in purchases. The top 3 suppliers — NATCO PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, STERIL-GENE LIFE SCIENCES PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Anastrozole corridor is one of India's established pharmaceutical export routes, with 53 shipments documented worth a combined $752.5K USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's anastrozole manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $14.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with anastrozole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 16.6%, placing it at rank #18 among India's top anastrozole export destinations globally.
On the import side, key buyers of Indian anastrozole in United Kingdom include LEXON UK LIMITED, Accord UK, CRESCENT PHARMA LIMITED and 11 others. LEXON UK LIMITED is the single largest importer with 3 shipments valued at $275.0K USD.
